New York Life Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-55,184
Closed -$784K 787
2025
Q3
$784K Buy
55,184
+9,502
+21% +$125K 0.01% 706
2025
Q2
$596K Buy
45,682
+3,291
+8% +$45.2K 0.01% 740
2025
Q1
$631K Buy
+42,391
New +$728K 0.01% 742
2024
Q2
Sell
-19,348
Closed -$362K 940
2024
Q1
$362K Buy
19,348
+3,875
+25% +$77.5K ﹤0.01% 1160
2023
Q4
$350K Sell
15,473
-454
-3% -$9.84K ﹤0.01% 1113
2023
Q3
$395K Sell
15,927
-2,538
-14% -$63.9K ﹤0.01% 885
2023
Q2
$518K Sell
18,465
-1,907
-9% -$47.4K 0.01% 695
2023
Q1
$455K Sell
20,372
-5,807
-22% -$152K 0.01% 1136
2022
Q4
$696K Buy
26,179
+2,810
+12% +$91.7K 0.01% 685
2022
Q3
$663K Buy
23,369
+1,849
+9% +$47.5K 0.01% 660
2022
Q2
$448K Buy
+21,520
New +$403K 0.01% 793

Other funds holding CCRN

New York Life Investment Management's CCRN Position: Q4 2025 in Review

New York Life Investment Management sold out of Cross Country Healthcare (CCRN) in Q4 2025, closing a stake of 55,184 shares — an estimated $784K sold.

New York Life Investment Management first reported a position in CCRN in Q2 2022 and held it in 11 quarters. The position peaked at $784K in Q3 2025. 147 funds tracked by Wall St. Rank hold CCRN as of Q4 2025.

  • New York Life Investment Management reported no remaining Cross Country Healthcare position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 55,184 Cross Country Healthcare shares in Q4 2025, an estimated $784K.
  • New York Life Investment Management first reported a position in Cross Country Healthcare in Q2 2022 and held it in 11 quarters.
  • New York Life Investment Management's Cross Country Healthcare position peaked at $784K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.